Myeloproliferative Neoplasm

Individuals prescribed the antidiabetes treatment metformin less likely developed a myeloproliferative neoplasm —potentially also reducing a person’s chances for developing certain cancers — according to data published in Blood Advances.

CHICAGO — In this video, Andrew Tiu, MD, discussed results from a study regarding the link between Agent Orange and myeloproliferative neoplasms, which he presented at ASCO Annual Meeting.

In this video, Srinivas K. Tantravahi, MBBS, MRCP(UK), discussed a case study, presented at the 14th International Congress on Myeloproliferative Neoplasms, of dizygotic twins.

Srinivas K. Tantravahi, MBBS, MRCP(UK), spoke with Healio about both nonpharmacologic interventions and pharmacologic developments for patients with myeloproliferative neoplasms.

In this video, Srinivas K. Tantravahi, MBBS, MRCP(UK), highlighted phase 2 data investigating hepcidin mimetics for polycythemia vera that appears to have eliminated the need for phlebotomy.

In this video, Brynn H. Parsegov, PA-C, highlighted two presentations from the 14th International Congress on Myeloproliferative Neoplasms.

Healio spoke with Brynn H. Parsegov, PA-C, about a presentation exploring the timing, as well as impact, of diagnosis for myeloproliferative neoplasms.

In this video, Brynn H. Parsegov, PA-C, discussed a case of fraternal female twins who sequentially presented with JAK2V617F mutation-positive myeloproliferative neoplasms.

In this video, Ann Mullally, MD, discussed her presentation investigating the use of therapeutic antibodies to target mutant calreticulin in myeloproliferative neoplasms.

John O. Mascarenhas, MD, spoke with Healio about takeaways from a presentation examining ways to optimize the currently available JAK2 inhibitors for the treatment of myelofibrosis.